Loblaw Companies Ltd
L: XTSE (CAN)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| <C | LOCK|cc! | LOCK|x!#qvx> |
Loblaw Earnings: Pharmacy and Discount Formats Offset Slow Food Retail Growth; Shares Overvalued
Loblaw's second-quarter results featured a 4.1% increase in revenue and an 8% jump in adjusted EPS to CAD 0.62. Food retail same-store sales grew 1.6%, while drug retail same-store sales rose 4.6%. Retail gross margin expanded 10 basis points to 32.2% due primarily to improvement in shrinkage.
